[1]
F. H. Rada, “ANTIPLATELET ADEQUACY OF CYCLOPENTYL TRIAZOLOPYRIMIDINE VERSUS CLOPIDOGREL IN-PATIENTS WITH CORONARY HEART DISEASE”, Asian J Pharm Clin Res, vol. 11, no. 12, pp. 536–539, Dec. 2018.